Carolina Hincapié-Osorno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Hincapié-Osorno has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Hjalmar R. Bouma
Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
6 shared publications - Jan Cornelis ter Maaten
Department of Acute Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
6 shared publications - Raymond Joram van Wijk
Department of Acute Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
6 shared publications - Douwe F. Postma
Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4 shared publications - Fabián Jaimes
Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
4 shared publications - Jacqueline Koeze
Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 173
Implications of different SOFA score variants for outcome prediction in emergency department patients with an infection: a multicenter cohort study
- 25 September 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 173
Open AccessImplications of different SOFA score variants for outcome prediction in emergency department patients with an infection: a multicenter cohort study
- Open Access
- 8 July 2026
- Published by Springer Nature in Internal and Emergency Medicine
- p. 1-12
Real-world clinical evaluation of the Inflammatix TriVerity test for sepsis at the emergency department: an Acutelines study
Early sepsis recognition is challenging due to its heterogeneous presentations and limited rapid diagnostic and prognostic tools. The TriVerity TM Test, a high-multiplex host-response mRNA point-of-care test, supports clinical decision-making by estimating infection likelihood and illness severity. This study assesses TriVerity’s accuracy in Dutch emergency department (ED) patients. Adult ED patients with suspected infection and Systemic Inflammatory Response Syndrome score (SIRS) ≥2 or quick Sequential Organ Failure Assessment (qSOFA) ≥2 were prospectively included by the Acutelines data/biobank. The TriVerity test provides three scores: likelihood of bacterial infection, viral infection, and illness severity. Infection status was determined post hoc by independent physicians through clinical consensus and forced adjudication. Illness severity was defined as ICU admission or death within 7 days after ED admission. Among the 467 patients included, 234 (50%) had a bacterial infection, 80 (17%) had a viral infection, 86 (18%) had a bacterial–viral co-infection, and 67 (14%) had no infection. For bacterial infections, the TriVerity assay demonstrated a rule-in specificity of 89–94% and a rule-out sensitivity of 87–92%, depending on the adjudication method (forced vs. consensus). For viral infections, the rule-in specificity was 92–95%, and the rule-out sensitivity ranged from 76 to 92%. The illness severity score showed a rule-in specificity of 83–86% and a rule-out sensitivity of 85–87%. The TriVerity test demonstrated high specificity and sensitivity for both bacterial and viral infections, with high sensitivity and modest positive predictive value in identifying patients at risk of developing severe illness.
- 8 July 2026
- Published by Springer Nature in Internal and Emergency Medicine
- p. 1-12
Open AccessReal-world clinical evaluation of the Inflammatix TriVerity test for sepsis at the emergency department: an Acutelines study
Early sepsis recognition is challenging due to its heterogeneous presentations and limited rapid diagnostic and prognostic tools. The TriVerity TM Test, a high-multiplex host-response mRNA point-of-care test, supports clinical decision-making by estimating infection likelihood and illness severity. This study assesses TriVerity’s accuracy in Dutch emergency department (ED) patients. Adult ED patients with suspected infection and Systemic Inflammatory Response Syndrome score (SIRS) ≥2 or quick Sequential Organ Failure Assessment (qSOFA) ≥2 were prospectively included by the Acutelines data/biobank. The TriVerity test provides three scores: likelihood of bacterial infection, viral infection, and illness severity. Infection status was determined post hoc by independent physicians through clinical consensus and forced adjudication. Illness severity was defined as ICU admission or death within 7 days after ED admission. Among the 467 patients included, 234 (50%) had a bacterial infection, 80 (17%) had a viral infection, 86 (18%) had a bacterial–viral co-infection, and 67 (14%) had no infection. For bacterial infections, the TriVerity assay demonstrated a rule-in specificity of 89–94% and a rule-out sensitivity of 87–92%, depending on the adjudication method (forced vs. consensus). For viral infections, the rule-in specificity was 92–95%, and the rule-out sensitivity ranged from 76 to 92%. The illness severity score showed a rule-in specificity of 83–86% and a rule-out sensitivity of 85–87%. The TriVerity test demonstrated high specificity and sensitivity for both bacterial and viral infections, with high sensitivity and modest positive predictive value in identifying patients at risk of developing severe illness.
- Open Access
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1850281
SOFA-2 represents meaningful progress toward a more inclusive and equitable global sepsis assessment framework
The updated Sequential Organ Failure Assessment (SOFA-2) score introduces important improvements in clarity, reproducibility, and global representation. By incorporating explicit scoring rules and data from a limited number of low- and middle-income countries (LMICs), it begins to address long-standing concerns regarding variability and applicability. However, substantial imbalances in data representation and health system capacity persist, and the extent to which these advances translate into improved calibration across diverse settings remains to be established. We argue that while SOFA-2 is a meaningful step forward, future sepsis frameworks must integrate context-specific evidence, account for structural constraints, and prioritize equitable participation in model development to ensure globally valid and clinically actionable tools.
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1850281
Open AccessSOFA-2 represents meaningful progress toward a more inclusive and equitable global sepsis assessment framework
The updated Sequential Organ Failure Assessment (SOFA-2) score introduces important improvements in clarity, reproducibility, and global representation. By incorporating explicit scoring rules and data from a limited number of low- and middle-income countries (LMICs), it begins to address long-standing concerns regarding variability and applicability. However, substantial imbalances in data representation and health system capacity persist, and the extent to which these advances translate into improved calibration across diverse settings remains to be established. We argue that while SOFA-2 is a meaningful step forward, future sepsis frameworks must integrate context-specific evidence, account for structural constraints, and prioritize equitable participation in model development to ensure globally valid and clinically actionable tools.
- Open Access
- 6 February 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (4) , 103170
Early risk assessment of severe outcomes in patients with suspected infection in the emergency department using clinical scores in a multicenter international validation
- 6 February 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (4) , 103170
Open AccessEarly risk assessment of severe outcomes in patients with suspected infection in the emergency department using clinical scores in a multicenter international validation
- Open Access
- 23 January 2026
- Published by Wiley in Academic Emergency Medicine
- Vol. 33 (1) , e70233
Acute Care Research Requires an Adapted Consent Procedure to Safeguard Participants' Autonomy and Rights While Limiting the Risk of Consent‐Bias
- 23 January 2026
- Published by Wiley in Academic Emergency Medicine
- Vol. 33 (1) , e70233
Open AccessAcute Care Research Requires an Adapted Consent Procedure to Safeguard Participants' Autonomy and Rights While Limiting the Risk of Consent‐Bias
- Open Access
- 30 October 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 161, 108155
Impact of methicillin-resistance on clinical outcomes in patients with Staphylococcus aureus bacteremia
- 30 October 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 161, 108155
Open AccessImpact of methicillin-resistance on clinical outcomes in patients with Staphylococcus aureus bacteremia
- 31 December 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 179, 111655
From introducing Table 0 to forgetting Figure 1: it is time for a reporting guideline for publishing with real-world clinical data—Response to de Kok et al
- 31 December 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 179, 111655
From introducing Table 0 to forgetting Figure 1: it is time for a reporting guideline for publishing with real-world clinical data—Response to de Kok et al
- Open Access
- 16 October 2024
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 43 (12) , 2441-2452
Validation of MEWS, NEWS, NEWS-2 and qSOFA for different infection foci at the emergency department, the acutelines cohort
Purpose: Sepsis is a leading cause of morbidity and mortality globally. The lack of specific prognostic markers necessitates tools for early risk identification in patients with suspected infections in emergency department (ED). This study evaluates the prognostic accuracy of various Early Warning Scores (EWS)—MEWS, NEWS, NEWS-2, and qSOFA—for in-hospital mortality, 30-day mortality, and ICU admission, considering the site of infection. Methods: A retrospective analysis was conducted using data from the Acutelines cohort, which included data collected from patients admitted to the University Medical Centre Groningen ED between September 2020 and July 2023. Patients were included if they had an ICD-10 code for infection. EWS were calculated using clinical data within 8 h post-admission. Predictive performance was assessed using AUC-ROC, calibration by the Hosmer-Lemeshow test and calibration curves, and operative characteristics like sensitivity and specificity. Results: A total of 1661 patients were analyzed, with infections distributed as follows: lower respiratory tract (32.9%), urinary tract (30.7%), abdominal (12.5%), skin and soft tissue (9.5%), and others (8.2%). The overall in-hospital mortality was 6.7%, and ICU admission was 7.1%. The highest AUC-ROC for in-hospital mortality prediction was observed with NEWS and NEWS-2 in abdominal infections (0.86), while the lowest was for qSOFA in skin and soft tissue infections (0.57). Predictive performance varied by infection site. Conclusions: The study highlights the variability in EWS performance based on infection site, emphasizing the need to consider the source of infection in EWS development for sepsis prognosis. Tailored or hybrid models may enhance predictive accuracy, balancing simplicity and specificity.
- 16 October 2024
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 43 (12) , 2441-2452
Open AccessValidation of MEWS, NEWS, NEWS-2 and qSOFA for different infection foci at the emergency department, the acutelines cohort
Purpose: Sepsis is a leading cause of morbidity and mortality globally. The lack of specific prognostic markers necessitates tools for early risk identification in patients with suspected infections in emergency department (ED). This study evaluates the prognostic accuracy of various Early Warning Scores (EWS)—MEWS, NEWS, NEWS-2, and qSOFA—for in-hospital mortality, 30-day mortality, and ICU admission, considering the site of infection. Methods: A retrospective analysis was conducted using data from the Acutelines cohort, which included data collected from patients admitted to the University Medical Centre Groningen ED between September 2020 and July 2023. Patients were included if they had an ICD-10 code for infection. EWS were calculated using clinical data within 8 h post-admission. Predictive performance was assessed using AUC-ROC, calibration by the Hosmer-Lemeshow test and calibration curves, and operative characteristics like sensitivity and specificity. Results: A total of 1661 patients were analyzed, with infections distributed as follows: lower respiratory tract (32.9%), urinary tract (30.7%), abdominal (12.5%), skin and soft tissue (9.5%), and others (8.2%). The overall in-hospital mortality was 6.7%, and ICU admission was 7.1%. The highest AUC-ROC for in-hospital mortality prediction was observed with NEWS and NEWS-2 in abdominal infections (0.86), while the lowest was for qSOFA in skin and soft tissue infections (0.57). Predictive performance varied by infection site. Conclusions: The study highlights the variability in EWS performance based on infection site, emphasizing the need to consider the source of infection in EWS development for sepsis prognosis. Tailored or hybrid models may enhance predictive accuracy, balancing simplicity and specificity.
- Open Access
- 29 December 2021
- Published by Universidad del Valle in Colombia Medica
- Vol. 52 (4) , e2044287
Validation and comparison of three mortality prediction scores in emergency department patients with community-acquired pneumonia
Background: qSOFA is a score to identify patients with suspected infection and risk of complications. Its criteria are similar to those evaluated in prognostic scores for pneumonia (CRB-65 - CURB-65), but it is not clear which is best for predicting mortality and admission to the ICU. Objective: validate and compare three scores (CURB-65, CRB-65 and qSOFA) to determine the best tool to identify emergency department patients with pneumonia who are at increased risk of mortality or intensive care unit (ICU) admission. Methods: Secondary analysis of three prospective cohorts of patients hospitalized with diagnosis of pneumonia in five hospitals in Medellin (Colombia). Validation and comparison of the score´s accuracies were performed by means of discrimination and calibration measures. Results: Cohorts 1, 2 and 3 included 158, 745 and 207 patients, with mortality rates of 32.3%, 17.2% and 18.4%, and admission to ICU was required for 52.5%, 43.5% and 25.6%, respectively. The best AUC-ROC for mortality was for CURB-65 in cohort 3 (AUC-ROC=0.67). The calibration was adequate (p>0.05) for the three scores. Conclusions: None of these scores proved to be an appropriate predictor for mortality and admission to the ICU. It is probable that the local context have modified their performance. It is necessary to validate the old ones and probably to develop new predictive models of prognosis for CAP in each country.
- 29 December 2021
- Published by Universidad del Valle in Colombia Medica
- Vol. 52 (4) , e2044287
Open AccessValidation and comparison of three mortality prediction scores in emergency department patients with community-acquired pneumonia
Background: qSOFA is a score to identify patients with suspected infection and risk of complications. Its criteria are similar to those evaluated in prognostic scores for pneumonia (CRB-65 - CURB-65), but it is not clear which is best for predicting mortality and admission to the ICU. Objective: validate and compare three scores (CURB-65, CRB-65 and qSOFA) to determine the best tool to identify emergency department patients with pneumonia who are at increased risk of mortality or intensive care unit (ICU) admission. Methods: Secondary analysis of three prospective cohorts of patients hospitalized with diagnosis of pneumonia in five hospitals in Medellin (Colombia). Validation and comparison of the score´s accuracies were performed by means of discrimination and calibration measures. Results: Cohorts 1, 2 and 3 included 158, 745 and 207 patients, with mortality rates of 32.3%, 17.2% and 18.4%, and admission to ICU was required for 52.5%, 43.5% and 25.6%, respectively. The best AUC-ROC for mortality was for CURB-65 in cohort 3 (AUC-ROC=0.67). The calibration was adequate (p>0.05) for the three scores. Conclusions: None of these scores proved to be an appropriate predictor for mortality and admission to the ICU. It is probable that the local context have modified their performance. It is necessary to validate the old ones and probably to develop new predictive models of prognosis for CAP in each country.